XML 64 R46.htm IDEA: XBRL DOCUMENT v3.22.0.1
Collaboration Agreements, License Agreement and Revenues - Summary of Revenue Recognized Under the Collaboration Agreements - Additional Information 4 (Detail)
12 Months Ended
Dec. 31, 2021
USD ($)
Japan [Member]  
Revenue Recognition Multiple Deliverable Arrangements [Line Items]  
Transaction price, variable consideration from estimated future co-development billing $ 0
Europe [Member]  
Revenue Recognition Multiple Deliverable Arrangements [Line Items]  
Transaction price, variable consideration from estimated future co-development billing 12,900,000
Europe [Member] | Astellas Agreement [Member]  
Revenue Recognition Multiple Deliverable Arrangements [Line Items]  
Changes in revenue due to prior period adjustment of performance obligations 1,000,000.0
U.S./RoW and China [Member]  
Revenue Recognition Multiple Deliverable Arrangements [Line Items]  
Transaction price, variable consideration from estimated future co-development billing 30,900,000
U.S./RoW and China [Member] | AstraZeneca Agreements [Member]  
Revenue Recognition Multiple Deliverable Arrangements [Line Items]  
Changes in revenue due to prior period adjustment of performance obligations $ 4,800,000